Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HCV-specific CD4<sup>+</sup> T-cells are susceptible to HIV-1 and contribute to viral persistence during antiretroviral therapy.

EBioMedicine·2026
Same author

Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).

Implementation science communications·2026
Same author

Increasing housing instability and changing spatial distribution of people who inject drugs in Montreal, Canada, 2011-2024.

Drug and alcohol dependence·2026
Same author

CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers.

Scientific reports·2026
Same author

Incidence of HIV and HCV Among People Who Inject Drugs in Montreal, Canada: Data From the HEPCO Longitudinal Cohort Study, 2011-2025.

Journal of viral hepatitis·2026
Same author

Peer-led recruitment for equitable engagement of people who inject drugs: Evidence from the HEPCO cohort in Montreal, Canada.

The International journal on drug policy·2026

Related Experiment Video

Updated: May 22, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Altered thymic function during interferon therapy in HCV-infected patients.

Stephanie Beq1, Sandra Rozlan, Sandy Pelletier

  • 1Département de Virologie, Institut Pasteur, Paris, France.

Plos One
|April 25, 2012
PubMed
Summary

Interferon alpha (IFNα) therapy for Hepatitis C causes T-cell lymphocytopenia by inhibiting thymic function and lowering IL-7. This impacts T-cell homeostasis and may increase infection risk.

More Related Videos

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Experiment Videos

Last Updated: May 22, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection poses a global health challenge.
  • Interferon alpha (IFNα) is an effective treatment for HCV but causes significant side effects.
  • A major side effect of IFNα therapy is T-cell lymphocytopenia, affecting immune homeostasis.

Purpose of the Study:

  • To analyze the early effects of IFNα therapy on thymic function and T-cell homeostasis.
  • To investigate these effects in patients with acute, chronic HCV, and HIV/HCV co-infection.
  • To explore the role of Interleukin-7 (IL-7) in IFNα-induced T-cell perturbations.

Main Methods:

  • Flow cytometry was used to assess T-cell subsets and homeostasis.
  • Thymic function was measured by quantifying T-cell receptor excision circles (TRECs).
  • Intrathymic precursor T-cell proliferation and plasma IL-7 concentrations were monitored during IFNα therapy.

Main Results:

  • IFNα therapy rapidly induced T-cell lymphocytopenia, affecting naive T-cells and recent thymic emigrants (RTEs).
  • Intrathymic T-cell proliferation was inhibited, and plasma IL-7 levels decreased significantly.
  • Decreased IL-7 correlated with reduced HCV viral load, thymic activity, and RTE counts.

Conclusions:

  • IFNα therapy profoundly impacts thymopoiesis and T-cell homeostasis, leading to lymphocytopenia.
  • This side effect may compromise treatment continuation and increase infectious risks, especially in co-infected patients.
  • Interleukin-7 (IL-7) may hold therapeutic potential for maintaining T-cell homeostasis during IFNα treatment.